임상교실 - 교수진 소개

이상우 교수

이상우 교수

이상우 / Sang-Woo Lee

  • 소속내과학교실
  • 직위명예교수
  • 세부전공소화기내과
  • 연구실위치
  • 구내전화번호산5580
  • 팩스
  • 이메일leesw@kumc.or.kr
학력사항
1976년 3월 ~ 1982년 2월 고려대학교 의과대학 의학사
1983년 3월 ~ 1985년 2월 고려대학교 대학원 소화기내과학 의학석사
1986년 3월 ~ 1989년 2월 고려대학교 대학원 소화기내과학 의학박사
교육 및 경력사항
1991년 3월 ~ 1992년 2월 고려대학교 의료원 내과임상강사
1992년 3월 ~ 1995년 2월 고려대학교 의과대학 내과학교실 조교수
1995년 2월 ~ 1996년 2월 미국 UCLA 소화기내과 교환교수
1995년 3월 ~ 2001년 2월 고려대학교 의과대학 내과학교실 부교수
2001년 3월 ~ 현재 고려대학교 의과대학 내과학교실 교수
2005년 12월 ~ 2007년 11월 고려대학교의료원 안산병원 진료부원장
2012년 1월 ~ 2013년 12월 고려대학교의료원 안산병원 병원장
학술활동
2001년 6월 ~ 2004년 12월 대한상부위장관?헬리코박터학회 학술위원장
2001년 12월 ~ 2004년 11월 대한소화기내시경학회 감사
2003년 12월 ~ 2005년 9월 대한소화기학회 재무이사
2001년 10월 ~ 2007년 10월 대한내과학회 고시위원
2004년 10월 ~ 2009년 10월 대한내과학회 평의원
2004년 11월 ~ 현재 대한소화기학회 평의원
2005년 11월 ~ 현재 대한소화기내시경학회 평의원
2008년 12월 ~ 2010년 11월 대한상부위장관?헬리코박터학회 부회장
2010년 12월 ~ 2012년 11월 대한상부위장관?헬리코박터학회 회장
2014년 10월 ~ 2015년 11월 대한소화기학회 차기 이사장
2015년 12월 ~ 2017년 11월 대한소화기학회 이사장
대표논문
Publication lists since 2008

1. Kim SY, Lee SW, Choe JW, Jung SW, Hyun JJ, Jung YK, et al. Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. Helicobacter 2017;22:e12441.

2. Choe JW, Kim SY, Hyun JJ, Jung SW, Jung YK, Koo JS, et al. Is the AIMS 65 Score Useful in Prepdicting Clinical Outcomes in Korean Patients with Variceal and Nonvariceal Upper Gastrointestinal Bleeding? Gut and Liver 2017;11:813-20.

3. Jung SW, Kim SY, Choe JW, Hyun JJ, Jung YK, Koo JS, et al. Standard and double-dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection. J Gastroenterol Hepatol 2017;32:778-81.

4. Shin WG, Lee SW, Baik GH, Huh KC, Lee SI, Chung JW, et al. Eradication Rates of Helicobacter pylori in Korea over the past 10 years and correlation of the amount of antibiotics use: nationwide survey. Helicobacter 2016;21:266-78.

5. Kang SH, Yim HJ, Kim SY, Suh SJ, Hyun JJ, Jung SW, et al. Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation. A retrospective cohort study. Medicine 95(8):e2903.

6. Choe JW, Jung SW, Song JK, Shim E, Choo JY, Kim SY, et al. Predictive factors of atelectasis following endoscopic resection. Dig Dis Sci 2016;61:181-8.

7. Joo MK, Park JJ, Kim H, Koh JS, Lee BJ, Chun HJ, et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract. Gastrointest Endosc 2016;83:318-26.

8. Jung SW, Lee SW. The antibacterial effect of fatty acids on Helicobacter pylori infection. Korean J Intern Med 2016;31:30-5.

9. Kim JH, Park J-J, Lee BJ, Joo MK, Chun HJ, Lee SW, et al. Astaxanthin inhibits proliferation of human gastric cancer cell lines by interrupting cell cycle progression. Gut Liver 2016;10:369-74.

10. Kim SY, Hyun JJ, Suh SJ, Jung SW, Jung YK, Koo JS, et al. Risk of vascular thrombotic events following discontinuation of antithrombotics after peptic ulcer bleeding. J Clin Gastroenterol 2016;50:E40-E44.

11. Kim HR, Yim HJ, Kang S, Suh SJ, Kim SY, Hyun JJ, et al. Efficacy of telbivudine compared with entecavir in hepatitis B virus?related cirrhosis: 2 year follow?up data. Liver International 2015;35:860-9.

12. Lee JM, Hyun JJ, Choi IY, Yeom SK, Kim SY, Jung SW, et al. Comparison on response and dissolution rates between ursodeoxycholic acid alone or in combination with chenodeoxycholic acid for gallstone dissolution according to stone density on CT scan: strobe compliant observation study. Medicine 2015;94:e2037

13. Choe JW, Jung SW, Lee SW. An unusual case of progressive dysphagia. Gastroenterology 2015;149:1337-8.

14. Joo MK, Park JJ, Kim SH, Yoo HS, Lee BJ, Chun HJ, et al. Antitumorigenic effect of plumbagin by induction of SH2?containing protein tyrosine phosphatase 1 in human gastric cancer cells. Int J Oncol 2015;46:2380-8.

15. Kim EH, Lee YC, Chang YW, Park J-J, Chun HJ, Jung H-Y, et al. Efficacy of lafutidine versus famotidine in patients with reflux esophagitis: a multi-center, randomized, double-blind, non-inferiority phase III trial. Dig Dis Sci 2015;60:1724-32.

16. Choi IK, Hyun JJ, Kim SY, Jung SW, Koo JS, Kim JH, et al. Influence of socioeconomic status on survival and clinical outcomes in patients with advanced gastric cancer after chemotherapy. Oncol Res Treat 2014;37:310-4.

17. Kang HS, Hyun JJ, Kim SY, Jung SW, Koo JS, Yim HJ, et al. Lemmel's syndrome, an unusual cause of abdominal pain and jaundice by impacted intradiverticular enterolith: case report. J Korean Med Sci 2014;29:874-8.

18. Kim SY, Hyun JJ, Jung SW, Koo JS, Yim HJ, Lee SW. Helicobacter pylori recurrence after first?and second?line eradication therapy in Korea: the problem of recrudescence or reinfection. Helicobacter 2014;19:202-6.

19. Lee OY, Kang D-H, Lee DH, Chung I-K, Jang J-Y, Kim J-I, et al. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment. Arch Pharml Res 2014;37:1308-16.

20. Lee SJ, Hwang JW, Yim H, Yim HJ, Woo SU, Suh SJ, et al. Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line. J Gastroenterol Hepatol 2014;29:1299-307.

21. Na YJ, Hyun JJ, Kim SY, Jung SW, Koo JS, Yim HJ, et al. Presumed pancreatic cyst proven to be venous malformation due to intestinal malrotation. Endoscopy 2014;46(S 01):E399-E400.

22. Suh KH, Koo JS, Hyun JJ, Choi J, Han JS, Kim SY, et al. Risk of adenomas with high?risk characteristics based on two previous colonoscopy. J Gastroenterol Hepatol 2014;29:1985-90.

23. Suh SJ, Yim HJ, Yoon EL, Lee BJ, Hyun JJ, Jung SW, et al. Is propofol safe when administered to cirrhotic patients during sedative endoscopy? Korean J Intern Med 2014;29:57-65.

24. Yoo IK, Choung RS, Hyun JJ, Kim SY, Jung SW, Koo JS, et al. Incidences of serious infections and tuberculosis among patients receiving anti-tumor necrosis factor-α therapy. Yonsei Med J 2014;55:442-8.

25. 한장수, 이상우, 서강흠, 김승영, 현종진, 정성우, 구자설, 임형준. 양잿물에 의한 식도협착 환자에서 편평세포암종으로 오인된 거짓상피종 증식 Korean J Gastroenterol 2014;63:366-8.

26. Kim SY, Lee SW, Hyun JJ, et al. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "Concomitant" therapy and 7-day standard triple therapy. J Clin Gastroenterol 2013;47:21?24.
27. Kim SY, Jung SW, Kim JH, et al.Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. Br J Clin Pharmacol 2012;73:140-143.
28. Lee SK, Lee SW, Park JY, et al. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy. Helicobacter 2011;16:410-414.
29. Song KH, Lee YC, Fan DM, et al. Healing effects of rebamipide and omeprazole in Helicobacter pylori- positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. Digestion 2011;84:221?229.
30. Kim N, Lee SW, Kim JI, et al. Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver 2011:5:437-446.
31. Hong SJ, Sung IK, Kim JG, et al. Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori-infected patients with functional dyspepsia. Gut Liver 2011;5:468-471.
32. Lee SK, Lee SW, Park JY, et al. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy. Helicobacter 2011;16:410-414.
33. Koo JS, Lee SW, Park SM, et al. Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction. Gut Liver 2009:3;276-284.
34. Jung SW, Lee SW, Hyun JJ, et al. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Dig Liver Dis 2009:41;134?140.
35. Koo JS, Park SM, Yim HJ, et al. Ileorectal anastomotic obstruction treated with a dual endoscopic transillumination technique. Endoscopy 2009;41:259
36. Kim JI, Kim SG, Kim N, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787-793.
37. Lee BJ, Park JJ, Chun HJ, et al. How good is cola for dissolution of gastric phytobezoars? World J Gastroenterol 2009;15:2265-2269.
38. Park SH, Lee SW, Song TJ. Another new variant of Bouveret's syndrome. World J Gastroenterol 2009;15:378-379.
39. Kim N, Park SH, Seo GS, et al. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. Helicobacter 2008;13:542-549.
40. Kim SY, Lee SW, Jung SW, et al. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump lnhibitor and clarithromycin: A randomized study. Helicobacter 2008;13:282-287.
41. Park S, Chun HJ, Kim CY, et al. Electrical characteristics of various submucosal injection, fluids for endoscopic mucosal resection. Dig Dis Sci 2008;53:1678-1682.
42. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008;27:173-185.

목록